Biomerieux SA - Unsponsored ADR Logo

Biomerieux SA - Unsponsored ADR (BMXXY)

OTC

Currency in USD
8.23
-0.33 (-3.87%)

Closed

Aug 21, 2026

Day's Range

8.23
8.23

52 wk Range

7.12
15.61

Overview - BMXXY - Biomerieux SA - Unsponsored ADR

Key Statistics

Valuation

Enterprise Value

11.03B

P/E (Trailing)

‪17.88‬

Price / Sales (TTM)

‪2.43‬

Price / Book

‪1.92‬

EV / EBITDA

‪8.99‬

Profitability

Profit Margin

‪11.59%‬

Operating Margin

‪15.23%‬

Return on Assets

‪7.23%‬

Return on Equity

‪11.22%‬

Ownership

Shares Outstanding

117.98M

Float

400.24M

Price stats

Beta

‪0.57‬

50-Day Avg

‪8.06‬

200-Day Avg

‪11.06‬

Dividends

Payout Ratio

‪25.33%‬

Frequency

Annual

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 19, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - BMXXY - Biomerieux SA - Unsponsored ADR

Peers - BMXXY - Biomerieux SA - Unsponsored ADR

Peer Comparison

Compared with companies in Diagnostics & Research listed on OTC.

Profile Summary - BMXXY - Biomerieux SA - Unsponsored ADR

About

Biomerieux SA is a global leader in in-vitro diagnostics, focusing on the development and production of systems used for clinical applications and industrial microbiological controls. An Unsponsored American Depositary Receipt (ADR) allows Biomerieux SA to trade in the U.S. financial markets, specifically on the…

SectorHealthcare
IndustryDiagnostics & Research
Employees14.56K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.